Zobrazeno 1 - 9
of 9
pro vyhledávání: '"AM Chica Marchal"'
Autor:
CN García Matillas, AM Chica Marchal, JM Montoya Egea, IM Fernandez Martinez, JM Martinez Marcos, J Fernandez Vela
Publikováno v:
Section 3: Production and compounding.
Autor:
García Simón, S Nuñez Bracamonte, AM Chica Marchal, CN García Matillas, E Conesa Nicolás, A Lloret Llorca, C Juez Santamaría, AC Viney, Mdm Sanchez Catalicio
Publikováno v:
Section 3: Production and Compounding.
Background Mucositis is a complication arising from chemotherapy that reduces the quality of life of a cancer patient. Its prevention and treatment are important. Purpose To evaluate the effectiveness and satisfaction of the suspension for mucositis
Autor:
AC Viney, A Lloret Llorca, C Juez Santamaría, E Conesa Nicolás, B Fernández-Lobato, M Martínez Penella, S Nuñez Bracamonte, CN García Matillas, AM Chica Marchal
Publikováno v:
Section 3: Production and Compounding.
Background As many medicines are not available for paedriatic use they have to be elaborated in the pharmacy service. Generally, there are different formulations described in the bibliography. Purpose To compare two liquid formulations of omeprazole
Autor:
MC González Pérez-Crespo, Mdm Sanchez Catalicio, C Juez, E Conesa Nicolás, CN García Matillas, S Nuñez Redondo, G Sarrió Montes, AM Chica Marchal, AC Viney, MH García Lagunar, A Lloret Llorca
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Fentanyl sublingual tablets are indicated for the management of breakthrough pain in cancer patients who are already receiving, and tolerant to, around-the-clock opioid therapy for persistent cancer pain. Purpose To evaluate the use of fen
Autor:
IG Pérez Pérez, S Nuñez Bracamonte, AM Chica Marchal, A Lloret Llorca, C Juez Santamaría, MH García Lagunar, AC Viney, I Muñoz García, E Conesa Nicolás, MC Mira Sirvent, M Martínez Penella
Publikováno v:
Eur J Hosp Pharm
Background Some drugs can be considered hazardous because of their potential to cause irreversible effects. Purpose To describe the actions carried out in a pharmacy service after the publication of Spanish National Institute of Occupational Health a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::690ea3e190bb069c893f86f0ec1deb7c
https://europepmc.org/articles/PMC7535529/
https://europepmc.org/articles/PMC7535529/
Autor:
MC González Pérez-Crespo, M Martínez Penella, MC Mira Sirvent, AM Chica Marchal, LM Escondrillas Gómez, A García Márquez, AC Viney, MH García Lagunar, B Fernández Lobato, I Muñoz García
Publikováno v:
Clinical pharmacy.
Background Viscosupplementation consists of intra-articular infiltration of hyaluronic acid (HA) to improve viscosity, reduce inflammation and relieve pain in patients with knee osteoarthritis. Purpose To compare the percentage of patients who requir
Autor:
A García Márquez, E Ferris Villanueva, AC Viney, R Guerrero Bautista, Mdr Gutiérrez Cívicos, A De Béjar Almira, C Fuentes Gutiérrez, MH García Lagunar, AM Chica Marchal, I Muñoz García
Publikováno v:
European Journal of Hospital Pharmacy. 23:A38.1-A38
Background Palivizumab is a monoclonal antibody that provides passive immunity against respiratory syncytial virus (RSV) and has very specific criteria for use that have changed recently. According to the literature data, the annual incidence of bron
Autor:
A García Márquez, E Ferris Villanueva, Mdr Gutiérrez Cívicos, D Lacruz Guzmán, M Martínez Penella, R Guerrero Bautista, I Muñoz García, MH García Lagunar, V Alice Charlotte, AM Chica Marchal
Publikováno v:
European Journal of Hospital Pharmacy. 23:A35.3-A36
Background Oncology patients are susceptible to malnutrition and this is a risk factor for morbidity and mortality. Purpose To evaluate nutritional status in patients treated with oral chemotherapy in a tertiary hospital. Material and methods Prelimi
Autor:
R Guerrero Bautista, AM Chica Marchal, MH García Lagunar, García Simón, A García Márquez, I Muñoz García, M Martínez Penella, Mdr Gutiérrez Cívicos, E Ferris Villanueva, D Lacruz Guzmán
Publikováno v:
European Journal of Hospital Pharmacy. 22:A13.2-A14
Background The use of drugs during pregnancy is always controversial. There is limited information about the use of infliximab during pregnancy. Purpose To describe the effectiveness and safety of infliximab in a patient with ankylosing spondylitis d